2% patients with respiratory infections tested positive for Covid-19: ICMR

About 40 per cent of Covid-19 cases with severe acute respiratory infection did not have any history of contact with a positive patient or international travel

Throat swab collection, coronavirus, testing kits, doctors, patients, hospitals, diagnosis
Throat swab collection demonstration at KIMS Hospital in Karnataka’s Hubballi on Wednesday Photo: PTI
BS Web Team
3 min read Last Updated : Apr 10 2020 | 9:03 AM IST

About 40 per cent of Covid-19 cases with severe acute respiratory infection did not have any history of contact with a positive patient or international travel, and they were reported from 36 districts of 15 states, an ICMR study found on Thursday while recommending these places for priority containment measures.

A total of 104 of the 5,911 patients with severe acute respiratory infections (SARI) tested positive for Covid-19, out of which 40 cases did not report any history of contact with a known case or international travel, according to the study.

Also, males accounted for higher number of Covid-19 cases and also patients aged above 50 years of age.

According to the study, which has been published in the Indian Journal of Medical Research, a total of (104) 1.8 per cent of the 5,911 SARI patients tested were positive for Covid-19.
 

These cases were reported from 52 districts in 20 states and union territories.

"In all, 39.2 per cent Covid-19 cases did not report any history of contact with a known case or international travel," the study said while two per cent reported contact with a confirmed case and one per cent reported recent history of international travel.

Data on exposure history was not available for 59 per cent cases.
 

ALSO READ: Coronavirus LIVE

The ICMR in its study highlighted that Covid-19 containment activities need to be targeted in districts reporting positive cases among SARI patients and stated that intensifying sentinel surveillance for Covid-19 among SARI patients may be an efficient tool to effectively use resources towards containment and mitigation efforts, it said.

Sentinel surveillance among SARI patients can help identify the spread and extent of transmission of Covid-19, the Indian Council of Medical Research said.
 

The SARI surveillance was initiated in the early phase of the Covid-19 outbreak in India.

In India, the initial Covid-19 testing strategy included people who had international travel history with symptoms, symptomatic contacts of laboratory-confirmed Covid-19 patients and symptomatic healthcare workers managing respiratory distress/SARI.

In addition, to track the progression of the epidemic in the early phase, stored samples of SARI patients hospitalised since February 15 were also tested for Covid-19 under the Virus Research and Diagnostic Laboratory Network (VRDLN).

As part of the study, SARI patients admitted at 41 sentinel sites from February 15 onwards were tested positive for Covid-19 by real-time reverse transcription-polymerase chain reaction.

During the study, SARI patients were detected from eight districts in Maharashtra, six in West Bengal and five each in Tamil Nadu and Delhi.

The chances of getting infected among SARI patients increased from 0 per cent before March 14, to 2.6 per cent by April 2.

In 15 Indian states, more than one per cent of SARI patients were Covid-19 positive.

About a third of Covid-19 positive SARI cases did not have any history of contact with laboratory-confirmed case or international travel, and such cases were reported from 36 districts in 15 states. These districts need to be prioritised to target Covid-19 containment activities, the study stated.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownFatal lung infectionshealthcare

Next Story